Navigation Links
Cambridge Major Appoints Professor John Hartwig as Scientific Advisor

Expertise in Catalysis and Chiral Chemistry Adds to CML's Technical


GERMANTOWN, Wis., Oct. 31 /PRNewswire/ -- Cambridge Major Laboratories announces the appointment of University of Illinois Professor John Hartwig as Scientific Advisor. Professor Hartwig is a world renowned expert in the application of catalysis to the synthesis of amines, halogens, and a variety of chiral transformations. His knowledge will play a vital role in advancing Cambridge Major's development of variety of chemical intermediates and Active Pharmaceutical Ingredients. He joins other prominent academics as part of CML's growing International Scientific Advisory Team.

Professor Hartwig's group has developed a series of catalytic reactions for organic synthesis, including palladium-catalyzed aminations of haloarenes, palladium-catalyzed alpha-arylation of carbonyl compounds, hydroaminations of vinylarenes and dienes, iridium-catalyzed enantioselective allylations of amines and alcohols, and the terminal functionalizations of alkanes. In addition, his group has uncovered new elementary organometallic reactions, such as reductive eliminations of amines, ethers and sulfides, insertions of olefins into transition metal amides and alkoxides, and the oxidative addition of ammonia.

John F. Hartwig received his A.B. from Princeton in 1986 and his Ph.D. from the University of California, Berkeley in 1990. Subsequently, he was an American Cancer Society Postdoctoral Fellow at the Massachusetts Institute of Technology and joined Yale University in 1992 where he was awarded the Irenee P. duPont Professorship in Chemistry in 2004. Dr. Hartwig joined the University of Illinois chemistry faculty in 2006 and currently holds the Kenneth J. Rinehart Jr. Professorship. John Hartwig has received numerous awards including an A.C. Cope Scholar (1998) Award, the Leo Hendrik Baekeland (2003) Award, the Thieme-IUPAC Prize in Synthetic Organic Chemistry (2004), the ACS Award in Organometallic Chemistry (2006), and the Tetrahedron Young Investigator Award in Organic Synthesis (2007).

"It has been a pleasure to become part of the synthetic chemistry community in the midwest, and I am looking forward to working with the experienced and skilled group of synthetic chemists at Cambridge Major Laboratories," said John Hartwig, Kenneth L. Rinehart Jr. Professor of Chemistry, University of Illinois.

"We are excited to have Professor Hartwig join our Scientific Advisory Team. His expertise will significantly help us to expedite synthesis of a wide range of pharmacologically active substances and their key intermediates," said Dr. Michael Major, President and CEO of Cambridge Major. "The addition of Professor Hartwig underscores our commitment to scientific excellence, and also our desire to provide our customers innovative and highly relevant chemistry that works."

Cambridge Major Laboratories, Inc. is a service-based chemistry outsourcing partner to the world's leading pharmaceutical and biotechnology companies, producing pharmaceutical intermediates, Active Pharmaceutical Ingredients, and other organic chemicals. Specializing in chemical process development and advanced multi-step organic synthesis, the Company operates two facilities near Milwaukee, Wisconsin including process chemistry laboratories, kilo labs, pilot plants, and complete analytical laboratories. The Company has been FDA inspected and approved for cGMP manufacturing. Visit us at

SOURCE Cambridge Major Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
2. Wisconsin building toward the major leagues of venture capital
3. Six things to consider before a major software implementation
4. New company eyes major ethanol production facility
5. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
6. University of Michigan plans major stem cell research center
7. BellBrook Labs gets major research funding
8. API announces major healthcare contracts
9. Top 20 big pharmas represent majority of world pharma market
10. Researchers report major advance in gene therapy technique
11. Sharon Ethanol appoints operations director
Post Your Comments:
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by ... known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , ... have embraced this type of racing and several new model aviation pilots have joined ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... the remaining 11,000 post-share consolidation (or 1,100,000 pre-share ... "Series B Warrants") subject to the previously disclosed ... 23, 2015, which will result in the issuance ... to the issuance of such shares, there will ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever that ... muscular dystrophy (DMD) has provided a new lead for ... Hospital, the Broad Institute of MIT and Harvard and ... . Cell, pinpoints a ... "escape" the disease,s effects. The Boston Children,s lab of ...
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
Breaking Biology News(10 mins):